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Abstract
Background: Previous reports suggest that omega-3 (n-3) polyunsaturated fatty acids (PUFA) supplements may
reduce ADHD-like behaviour. Our aim was to investigate potential effects of n-3 PUFA supplementation in an
animal model of ADHD.
Methods: We used spontaneously hypertensive rats (SHR). SHR dams were given n-3 PUFA (EPA and DHA)-
enriched feed (n-6/n-3 of 1:2.7) during pregnancy, with their offspring continuing on this diet until sacrificed. The
SHR controls and Wistar Kyoto (WKY) control rats were given control-feed (n-6/n-3 of 7:1). During postnatal days
(PND) 25–50, offspring were tested for reinforcement-dependent attention, impulsivity and hyperactivity as well as
spontaneous locomotion. The animals were then sacrificed at PND 55–60 and their neostriata were analysed for
monoamine and amino acid neurotransmitters with high performance liquid chromatography.
Results: n-3 PUFA supplementation significantly enhanced reinforcement-controlled attention and reduced lever-
directed hyperactivity and impulsiveness in SHR males whereas the opposite or no effects were observed in
females. Analysis of neostriata from the same animals showed significantly enhanced dopamine and serotonin
turnover ratios in the male SHRs, whereas female SHRs showed no change, except for an intermediate increase in
serotonin catabolism. In contrast, both male and female SHRs showed n-3 PUFA-induced reduction in
non-reinforced spontaneous locomotion, and sex-independent changes in glycine levels and glutamate turnover.
Conclusions: Feeding n-3 PUFAs to the ADHD model rats induced sex-specific changes in reinforcement-motivated
behaviour and a sex-independent change in non-reinforcement-associated behaviour, which correlated with
changes in presynaptic striatal monoamine and amino acid signalling, respectively. Thus, dietary n-3 PUFAs may
partly ameliorate ADHD-like behaviour by reinforcement-induced mechanisms in males and partly via
reinforcement-insensitive mechanisms in both sexes.
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Introduction
Attention deficit hyperactivity disorder (ADHD) which
affects ~5% of children [1] is characterized by attention
deficit, hyperactivity and impulsiveness [2], with three
times higher prevalence among boys than girls [3]. The
etiology of ADHD is unknown, but meta-analyses sug-
gest a strong genetic component based on hereditary
estimates in twin-studies of ~76% [4]. Although high,
the concordance of monozygotic twins is not perfect,
suggesting that environmental factors may act in addi-
tive or interactive ways with the genetic influence [5,6].
The cognitive dysfunction in ADHD may be affected
by a lack of omega-3 (n-3) polyunsaturated fatty acids
(PUFAs) during embryonic development and early life
[7-9]. Although humans are able to synthesize the
omega-6 (n-6) fatty acid (FA) arachidonic acid (AA)
from linoleic acid (LA), and the n-3 FAs like eicosa-
pentaenoic acid (EPA) and docosahexaenoic acid (DHA)
from alpha-linolenic acid (ALA), these processes are
slow and ineffective in most mammals [10], and they
are also influenced by different factors like sex hor-
mones, n-6/n-3 intake ratio and saturated fatty acid
intake. Specifically, the capacity of males to transform
ALA to DHA appears to be very low, and dietary access
to DHA may thus perhaps be particularly important for
males [11,12]. From the nutritional and anthropological
point of view, humans have developed on a diet with a
fair amount of n-3 FAs, whereas many industrial diets
contain little of these fatty acids [13].
A lack of n-3 PUFAs in the diet of children and, con-
versely, feeding of n-3 PUFA to pregnant women and
mothers may influence cognitive abilities in the offspring
[14-20], and potentially affect the prevalence of ADHD
[21-23]. Experimental studies have suggested that dietary
supplementation with n-3 PUFAs may enhance both
synaptic development and function [9,24,25]. Different
fatty acids in neurons and glia cells might change the
properties of surface and intracellular membrane com-
partments, membrane-associated proteins, gene tran-
scription, neurotransmitter metabolism and activities of
synaptic vesicles and transporters [13,26,27]. Previous
work has also indicated a possible link between ADHD
and disturbances in dopaminergic function [28-32], with
downstream connections to serotonergic and glutama-
tergic transmissions [33,34].
In the present study we employed the spontaneously
hypertensive rat (SHR), a well validated genetically deter-
mined ADHD model [35-37], to examine whether
increased access to n-3 PUFAs during pregnancy and de-
velopment may modulate behavioural symptoms and
brain neurotransmitter metabolism [38]. Pregnant SHR
dams and their offspring were fed extra n-3 PUFAs, fol-
lowed by behavioural testing of the offspring in standard
operant chambers to monitor reinforcement-controlled
levels of activity, impulsivity and attention [39]. Moreover,
video-recordings of the animals during operant testing
were used to assess general locomotion. Because activity-
related behaviours in rodents may be influenced via
neurotransmitter interactions between dopamine (DA),
serotonin (5-HT) and glutamate (Glu) located in neostria-
tal synapses [33,34], we subsequently measured the levels
of these transmitters and their metabolites in neostriatal
extracts from the very same SHR animals which had been
studied behaviourally. Our results indicate that n-3 PUFA
feeding may ameliorate reinforcement- and monoamine-
dependent ADHD symptoms in a sex-specific manner,
whereas other symptoms, independent of reinforcement
and possibly correlated to changes in amino acid transmit-
ters, were ameliorated to the same extent in both sexes.
Methods
Animal models
The study was approved by the Norwegian Animal
Research Authority, and conducted in accordance with
the laws and regulations controlling experiments on live
animals in Norway. Spontaneously Hypertensive Rodents
(SHR/NCrl) purchased from Charles River, Sulzfeld,
Germany, were used as breeding subjects. During the
first three weeks of life, the rats were under veterinarian
care at the Norwegian Defence Research Establishment
(Kjeller, Norway). Dams were caged singly under stand-
ard conditions (temperature ~22°C, humidity ~55%,
12 h light/dark cycle), with free access to water. The vet-
erinarian administered feeding of either n-3 PUFA-
enriched diet or chow to dams before breeding, under
pregnancy and after birth. At postnatal day (PND) 25, 36
rats were shipped to the University of Oslo for behav-
ioral testing. Thereafter, offspring of both sexes were
fed similar diets as their parents, until sacrifice at PND
55–60. The weight was measured continously on SHR-
rats from each experimantal group troughout the study.
In order to obtain the growth rate, body weight was
measured continuously on SHR-rats from each experi-
mental group throughout the study. In the males, the
n-3 PUFA diet increased the growth rate by 7.7% com-
pared to the control-diet (with p = 0.01 and n = 8 and
n= 11 respectively). Whereas n-3 PUFA diet had no
effect on the female growth rate (p = 0.1, control diet;
n = 10 and n-3 PUFA diet; n = 7).
Experimental diet
The experimental group was given a semi-synthetic n-3
enriched feed, as described in Rokling-Andersen et al.
2009 [40]. This feed was high on the essential n-3
PUFAs EPA and DHA with 9.1% (w/w) lard and 10.4%
Triomar (EPAX5500) delivered by Pronova Biocare,
Lysaker, Norway. Triomar contained 55% of total n-3 FA
as TAG including EPA, 300 mg/g; DHA, 190 mg/g; total
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n-3 FA, 580 mg/g (made up of EPA, DHA, ALA, steari-
donic acid, eicosatetraenoic acid, heneicosapentaenoic
acid, and docosapentaenoic acid). This dose represents
about 3.6% of total energy intake of the rats and is com-
parable to traditional Inuit intake of marine FA [15]. In
addition, 1.5% of soybean oil (Mills Soyaolje; Denofa Lil-
leborg, Fredrikstad, Norway) was provided to avoid es-
sential n-6 FA deficiency.
The dietary composition (g/100 g food) was: total fat,
21; sucrose, 20; starch, 31.5; protein, 20; cellulose, 1;
vitamin mixture, 1.5 and salt mixture, 5. Vitamin (Cat
No: 904654) and salt mixture (Cat No: USP XVII) was
bought from MP Biochemicals LLC. The feed was kept
at −20°C and given to the rats in portions sufficient for
1 day supply.
Control-feed
The control SHRs were given lab chow (RM3 (E) from
Special Diet Services, Witham, Essex CM8 3 AD, UK,
www.sdsdiets.com/pdfs/RM3-E-FG.pdf ). This feed is low
on EPA and DHA, and has a n-6 to n-3 ratio of about
7:1. The fatty acid composition of this feed (w/w) were
as follows: saturated fatty acids: lauric acid, 0.5 mg/g;
myristic acid, 2 mg/g; palmitic acid, 3.6 mg/g; stearic
acid, 0.9 mg/g and monounsaturated fatty acids: myris-
toleic acid, 0.1 mg/g; palmitoleic acid, 1.3 mg/g; oleic
acid, 10.3 mg/g and PUFAs: LA, 11.5 mg/g; ALA,
1.7 mg/g; AA, 2.2 mg/g; docosapentaenoic acid, 0.4 mg/g.
The dietary composition (g/100 g food) was: total fat, 4.2;
sucrose, 5.7; starch, 33.9; protein, 22.4; cellulose, 3.9;
hemicellulose, 9.2; dietary fibre, 15.4; vitamin mixture, 0.5
and salt mixture, 4.6. The diet was kept at −20°C until fed
to the animals.
Behavioural analyses
At PND 21 the offsprings were moved to a separate lo-
cation for behavioural testing. All 41 sessions included
habituation, training, shaping and testing with reinfor-
cers. The duration and reinforcement scedule of the dif-
ferent sessions is described in the summary of the
experimental procedure (Table 1). Sessions used in the
analyses lasted for 90 min.
A total of 36 animals were tested using a two-lever vis-
ual discrimination task [39] with one session each day
for 34 days (the last 28 sessions were used in the ana-
lyses). The animals were also video-recorded during the
operant task in sessions 13, 24, and 34 to monitor spon-
taneous locomotion, and the results were averaged for
each rat. The n-3 PUFA-fed group included 8 males and
7 females, whereas 11 males and 10 females served as
control-fed reference animals. Testing of the experimental
and control groups took place at different time points.
During habituation and response acquisition, two offsprings
were housed in one transparent cage 41 × 25 × 25 cm
(height), whereas during response acquisition and through-
out the rest of the study, the animals were housed indi-
vidually in the same type of cages. The rats had free access
to water during the habituation sessions, following which
they were deprived of water for 21 h a day throughout the
rest of the study. The behavioural testing took place be-
tween 0900 and 1400 h.
Table 1: Summary of the behavioural procedures and
reinforcement schedule.
Apparatus
The animals were tested in 16 operant chambers (Campden
Instruments) enclosed in sound-resistant outer housings
[39,41]. The chambers were ventilated and equipped with a
grid floor, and the animals’ working space was 25 × 25 × 30
(height) cm. The chambers were equipped with two
retractable levers requiring a dead weight of at least 3 g
to activate a micro-switch. A 2.8 W cue light was
located above each lever. The reinforcer (0.05 mL tap
water) was delivered by a liquid dipper located in a
small recessed cubicle, where a 2.8 W cue light lit up.
A 7 × 5 cm transparent plastic top-hinged flap separated
the cubicle from the animal’s working space. The
computer program LabVIEW 7.1 (National Instruments
LabVIEW, Austin, Texas, USA, 2004) recorded the
behaviour and scheduled reinforcements and lights.
Each operant chamber was equipped with a video ca-
mera (Mini Color Hidden Cameras (420TVL, 0,1lux)
from Tracer Technology Co. Ltd, Taiwan) positioned to
capture the entire working space, in the upper rear
corner of the ceiling at an angle of 45 o. The DVR Live
Capture computer program (Novus Security, 2009,
Warsaw, Poland) controlled the cameras and saved the
video files for analyses.
Operant testing
Prior to behavioural testing, the rats were semi-
randomly assigned an operant chamber. Following ha-
bituation in the operant chamber, the animals were
trained to lever-press and then run for additional
Table 1 The reinforcement was given using either a fixed
time schedule of reinforcement (FT), continuous
reinforcement schedule (CRF) or a variable interval
schedule of reinforcement (VI)
Behavioral procedure Session
number
Reinforcement
schedule
Habituation, 30 min 1
Magazine training, 30 min 2 – 3 FT 10 seconds
Flap training 4 – 5 CRF
Shaping of lever-pressing 6 – 7
30 minutes session 8 – 13 VI 3 seconds
90 minutes session, 16 chambers 14 – 41 VI 180 seconds
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sessions to strengthen the newly learned behaviour. In
the operant task, two levers were used. Pressing the
lever, which was signalled by a lit cue light located above
the lever, produced reinforcements according to a vari-
able interval 180 s schedules of reinforcement (VI 180 s).
During this period, the cue light above the alternative
lever was off, and lever press had no consequences.
During reinforcer delivery, the cue light above the lever
was turned off, and a 2.8 W cue light was lit in the water
cubicle. The lever producing reinforcers alternated un-
predictably between the two lever-alternatives, but stayed
the same until a reinforcer was produced by a lever-press.
Following reinforcer delivery, the computer program
semi-randomly selected which lever would produce the
next reinforcer. To avoid development of lever-prefe-
rences, the program allowed a maximum of four con-
secutive reinforcers on the same lever.
Measure of reinforcement-controlled behaviour
Recording was made of number of presses on the
reinforcer-producing lever and on the alternative lever,
number of reinforcers produced and collected, and the
time of the events. Percentage of responses on the lever
producing reinforcers (for all responses, and for the first
response following reinforcer delivery), and the time be-
tween two responses (inter-response time, IRT), were
calculated. Attention was operationalized as the percent-
age of responses on that lever which produced reinfor-
cers (the animal had to pay attention to and press the
lever signalled by the lit cue light above the lever, i.e.
stimulus control). Hyperactivity was operationalized as
the total number of lever-presses on the two levers com-
bined. The IRTs were split into responses with IRTs
longer than 0.67 s and shorter than 0.67 s. Number of
responses with short IRTs (< 0.67 s) was used as a meas-
ure of impulsivity (“premature responding” or “inability
to wait”).
Video recordings
The animals were video-recorded during the operant
task in 3 sessions, which were chosen to represent the
spontaneous activity early, in the middle of and late in
the experimental testing period. The cameras recorded
15 frames per second, and frame-to-frame analyses of
changes in pixels, which occurred whenever the animal
moved, were performed by using the computer program
Musical Gestures Toolbox for audio and video analysis
[42]. The total number of pixel-changes was used to
quantitate movements. Each of the 3 sessions was divided
into 5 segments in order to analyse within-session changes
in locomotion in the experimental and control groups. To
reduce noise, pixel-changes were averaged across 15
frames and a noise reduction threshold (0.25) and filter (8)
were used.
Analysis of behavioural data
All statistical analyses were performed in Statistica 6.0
(StatSoft. Statistica for Windows, StatSoft Inc., Tulsa,
OK, 2005). Data were evaluated either by multivariate
analyses using Wilks lambda (MANOVAs) when the
degrees of freedom relative to the number of levels of
the repeated factor permitted this approach, or by uni-
variate analyses of variance (ANOVAs), adjusting the
degrees of freedom with the Huynh–Feldt epsilon [43].
Sessions were used as the within-individual factor in the
operant task, whereas sessions and segments were used as
the within-individual factor in the video analyses. n-3
PUFA-feeding was used as the between-individuals factor
in both analyses. Session were included as a factor to look
for changes in behaviour across development. Post-hoc
tests on main effects were performed using the Unequal
N HSD test. Preparation of graphs was performed using
Prism (GraphPad Software Inc.) and the graphs represent
means ± SEM for each group (n = 7–11).
Biochemical analyses
Chemicals
Monoamine and amino acid analyses were done with
high performance liquid chromatography (HPLC).
L-amino acid standards, including aspartic acid (Asp),
glutamic acid (Glu), serine (Ser), glutamine (Gln) and
glycine (Gly) were obtained from Pierce (Rockford, Ill.,
USA), whereas taurine (Tau), γ-amino butyric acid
(GABA), and α-amino adipic acid were from Sigma
(Sigma-Aldrich, Steinheim, Germany). The monoamine
standards dopamine (DA), homovanillic acid (HVA),
serotonin (5-HT), 5-hydroxyindole-3-acetic acid (HIAA)
and 3,4-hydroxybenzylamine (DHBA), as well as HClO4
and ascorbic acid were also obtained from Sigma. The
BCA-assay kit (Thermo-Scientific, Rockford, USA), and
n-hexane (Merck, Darmstadt, Germany) were bought
from VWR. Solutions were made with purified distilled
water (Milli-Q Advantage A10, Millipore).
Sample collection
Following behavioural testing, the SHR rats as well as
age-matched Wistar Kyoto rats (WKY/NHsd) [37] were
stunned and rapidly decapitated at PND 55–60 (the
WKY/NHsd were used as additional reference strain in
the biochemical analyses). The neostriata were removed,
frozen in liquid N2, and stored at −70°C until sample
preparation and analyses.
Extract preparation and protein assay
The tissues were rapidly weighed and homogenized by
hand with 20 strokes in 500 μL ice cold 0.2 M HClO4,
using a glass/teflon Potter-Elvehjem homogenizer. This
suspension was mixed with an equal volume of DHBA
(used as internal standard for monoamines) in 0.12 mM
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ascorbic acid to a final concentration of 0.227 μM
DHBA. The homogenates were centrifuged for 20 min at
15000 × g at 2°C in a Sorvall RMC-14-microcentrifuge.
The pellets were frozen at −40°C for later protein deter-
mination, performed by dissolving pellets in 0.1 M
NaOH and measuring protein content by the BCA assay
[44]. The supernatants were extracted with equal
volumes of n-hexane to reduce lipid contamination, and
the top layer was discharged. For amino acid analyses,
parts of the delipidized HClO4 extracts were mixed with
a solution of α-amino adipic acid (used as internal stand-
ard) to a final concentration of 10 μM in a total volume
of 1.9 mL. These extracts were neutralized to pH 7.2
with ice cold KOH and centrifuged for 20 min at
15000 × g at 2°C as described above. The supernatants
were stored at −70°C until analyses. The samples were
then transferred into glass-vials by filtering through
Nylon-66 micro filters (0.22 μm) from Nalgene (Rochester,
New York, USA), before HPLC analysis.
Monoamine analysis
Column and mobile phases were selected for analysis of
catecholamine content in plasma and was supplied by
Chromsystems (Germany). The frozen extracts were
used directly for analyses of total DA and 5-HT, as well
as their metabolites HVA and 5-HIAA, using a reversed-
phase HPLC (Shimadzu, Kyoto, Japan) with electro-
chemical detection (ECD; Decade II with Sencell flow
electrode, Antec Leyden) set to a working potential of
0.6 V. Each sample was eluted for 40 min with a flow
rate at 1.3 mL/min and a representative chromatogram
is shown in Figure 1b. External standard solutions of DA,
HVA, 5-HT, 5-HIAA and DHBA were analysed on the
same day. The chromatograms were analysed using the
software Lab Solutions (Shimadzu). Monoamine concen-
trations are expressed in pmol/mg total neostriatal protein.
Amino acid analysis
Using a Chromspher 5 C18 column of 25 cm length and
4.6 mm inner diameter (Varian), total amino acids in
the neostriatum extracts were analysed [45], using
reversed-phase HPLC fitted with a fluorescence detector
(Shimadzu, Kyoto, Japan) after derivatization with
o-phthaldialdehyde (OPA; Sigma). The mobile phase
comprised 75% 50 mM phosphate buffer, pH 5.25, and
25% methanol (v/v), changing linearly to 25% phosphate
buffer and 75% methanol during 26.5 min, after which
the methanol concentration was linearly reduced to 15%.
Each sample was eluted for 45 min with a flow rate at
0.4 mL/min and a representative chromatogram is
shown in Figure 1a. A mixture of the amino acids of
interest was used as external standards in a concentra-
tion of 100 μM. The chromatograms were analysed
using the software Lab Solutions (Shimadzu). Amino
acid concentrations are expressed in nmol/mg total
neostriatal protein.
Statistical analysis
Statistical significance of biochemical differences between
samples was determined by unpaired, two-tailed Student’s
t-test, where p < 0.05 is defined as significant. Level of sig-
nificance is symbolized with * (p-value ≤ 0.05), ** (p-value ≤
0.01 and *** (p-value ≤ 0.001). Statistical analyses as well
as preparation of graphs were performed using Prism
(GraphPad Software Inc), and the graphs display the
means ± SEM for each group (n = 4–8).
Results
Behavioural analysis
Operant testing
Overall, n-3 PUFA supplementation interacted with sex
in the SHR animals, improving percentage of presses on
the lever producing reinforcers (stimulus control) in n-3
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Figure 1 Chromatographic profiles of rat neostriatal extracts. (a) Amino acids in a WKY control-fed female, and (b) monoamines in a
control-fed SHR male. Panel a) shows the peaks of aspartic acid (asp), glutamate (Glu), serine (Ser), glutamine (Gln), α-amino adipic acid (AAA),
glycine (Gly), taurine (Tau) and γ-amino butyric acid (GABA). Panel b) shows the peaks of 5-hydroxyindol-3-acetic acid (5-HIAA), homovanillic acid
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PUFA-fed males, but having the opposite effect in females
(Figure 2a-2b). Analyses of stimulus control for all lever
presses showed a statistically significant main effect of
session (F(2,31) = 11.31; p < 0.01). Trends were observed
for a main effect of sex (F(1,32) = 3.45; p = 0.07), and for a
sex × feed condition interaction (F(1,32) = 3.66; p = 0.06).
Analyses of stimulus control for the first lever press
following reinforcer delivery (Figure 2a) also showed
a statistically significant sex × feed condition interaction
effect (F(1,32) = 5.99; p = 0.02). No significant effects were
found in the Unequal N HSD post-hoc analyses of the
significant sex × food condition interaction effect.
No statistically significant effects were observed during
analyses of number of reinforcers collected. Out of the
possible 30 reinforcers per session, the mean number
of reinforcers collected was similar in all groups across
sessions, and ranged from 28.3 (n-3 PUFA-treated males,
session 27) to 29 (control-fed male SHRs, session 6).
Number of responses with short IRTs was decreased
in n-3 PUFAs supplemented males but increased in n-3
PUFA supplemented females (Figure 2c). The analyses
showed a significant main effect of session (F(2,31) =
4.23; p = 0.02) and a significant sex × feed condition
interaction (F(1,32) = 5.81; p = 0.02). Also, a significant
sex × feed condition × session interaction was found
(F(2,31) = 5.60; p < 0.01). No significant effects were
observed in the post-hoc analyses of the significant sex ×
feed condition interaction effect using the Unequal N
HSD test.
Supplementation with n-3 PUFAs reduced lever-
directed hyperactivity in males and increased hyperac-
tivity in females (Figure 2d). The analyses showed
significant main effects of sex (F(1,32) = 6.23; p = 0.02),
session (F(2,31) = 8.62; p < 0.01) and a significant sex ×
feed condition interaction (F(1,32) = 4.94; p = 0.03).
Unequal N post-hoc analyses of the significant sex ×
food condition interaction showed that control-fed SHR
males emitted significantly more lever-presses than
control-fed female SHRs (p = 0.01).
Locomotor testing
Analyses of video data showed that n-3 PUFA-supple-
mented rats had reduced locomotion in the initial seg-
ments of the sessions in both males and females
(Figure 3). The analyses showed significant main
effects of session (F(2,30) = 8.63; p < 0.01) and segment
(F(4,28) = 14.77; p < 0.001,) as well as significant sex ×
segment (F(4,28) = 3.29; p < 0.03), feed condition × seg-
ment (F(4,28) = 4.63; p < 0.01) and session × segment
(F (8,24) = 6.31; p < 0.001) interaction. In addition, the
analyses showed a significant sex × feed condition × ses-
sion interaction (F(2,30) = 3.54; p = 0.04) and a sig-
nificant food condition × session × segment interaction
(F(8,24) = 2.44; p = 0.04). This means that all the SHRs
increased their general activity between early and middle
session, and within sessions there was a decrease in gen-
eral activity across segments. The males showed
more general activity across segments relative to female
SHRs. Comparison of general movement for PUFA-
supplemented SHR vs. SHR control showed that general
movement was significantly different for the first seg-
ment, using unpaired two-tailed Student’s t-test.
Behavioural summary
Taken together, n-3 PUFA supplementation significantly
enhanced reinforcement-controlled attention (Figure 2a-b)
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producing lever) for the first lever-press following reinforcer delivery (sex × supplementation, F1,32 = 5.99, p = 0.02); (b) Attention (stimulus control;
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and reduced lever-directed hyperactivity (Figure 2d) and
impulsivity in SHR males (Figure 2c), whereas the opposite
or no effects were observed in females (Figure 2c-d). In
contrast, general locomotion was reduced by n-3 PUFA-
feeding to a similar extent in both sexes (Figure 3).
Biochemical analyses
Monoamine transmitters
Dietary supplementation with n-3 PUFA to the dams
and offspring changed DA and 5-HT dynamics in the
SHR neostriata in a sex-specific manner, with significant
effects in the male SHR offspring only. DA levels
were reduced by 30 ± 11% in the n-3 PUFA-fed male
SHRs (n = 4) as compared to control-fed male SHRs
(n = 8), p = 0.03. In all other animals, DA levels
remained similar to the WKY controls (Figure 4a). In the
neostriatum, DA is exclusively present in the terminals
of the nigrostriatal fibers, with DA levels representing a
balance between DA release, DA reuptake/synthesis and
DA degradation. Thus, we compared levels of DA with
the DA degradation product HVA, a measure indicating
biochemical DA utilization in dopaminergic synapses
[46,47]. Males fed n-3 PUFA showed a 80 ± 18% increase
in HVA levels (n = 4) in neostriatum (Figure 4b), leading
to a HVA/DA ratio of 0.22 ± 0.04 in the male SHR,
which was more than twice that obtained in the female
SHR and the control-fed SHR and WKY (Figure 4c).
Similar to the DA system, 5-HT in the neostriatum is
exclusively present in nerve terminals [28]. In the WKY
controls, total 5-HT levels were similar in both sexes,
whereas in the SHRs, they were slightly higher in
control-fed males than females. This sex difference was,
however, obliterated by n-3 PUFA supplementation, with
5-HT levels decreasing by 40 ± 18% in the males (n = 4)
as compared to control-fed SHR (n = 8, p = 0.06),
whereas the female 5-HT levels remained unchanged
after n-3 PUFA supplementation. At the same time, n-3
PUFA feeding enhanced the levels of the degradation
product 5-HIAA [28] in both sexes (Figure 5b), with the
5-HIAA/5-HT ratios indicating 5-HT turnover rates of
4.8 ± 1.7 (n = 4) and 4.5 ± 1.2 (n = 4) in the male and fe-
male n-3 PUFA-fed SHRs, respectively. In contrast,
control-fed male and female SHRs had ratios of 1.3 ± 0.4
and 3 ± 1.1, respectively, whereas WKY controls of
both sexes showed ratios of 1.1 ± 0.1 (n = 5) and 1.2 ± 0.1
(n = 5), respectively (Figure 5c). Thus, PUFA-feeding
enhanced 5-HT utilization in the SHRs to the same
levels in both sexes. Interestingly, the statistically signifi-
cant effect was restricted to the males, whereas the fe-
male SHR showed a partial increase already without
PUFA supplements.
Amino acid transmitters
Supplementation with n-3 PUFA also modulated
amino acid transmitters in the neostriata. Recent
studies suggest that Gln/Glu ratios may indicate the
efficacy of presynaptic glutamatergic signalling in vivo
[48,49], In our study, levels of the major excitatory
transmitter Glu were reduced in n-3 PUFA-fed SHRs
of both sexes, with males showing a significant reduc-
tion of 22% (n = 4, p = 0.02). And a similar effect oc-
curring in the females (Figure 6a). In contrast, levels
of the precursor/metabolite amino acid Gln remained
stable in SHRs of both sexes (Figure 6b), leading to
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Figure 3 Analysis of general locomotion. Video analyses of pixel-changes showed that n-3 PUFA supplementation reduced locomotion in the
initial 18 min segments of the 90 min sessions in both males and females. For the first segment, comparison of general movement for PUFA-
supplemented SHR vs. SHR control is significantly different, as symbolized by * (p ≤ 0.05), using unpaired two-tailed Student’s t-test. Data are
presented as means ± SEM (n = 7–11).
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significantly higher Gln/Glu ratios in both sexes of n-
3 PUFA-fed SHRs when compared to control-fed
SHRs. Specifically, control SHRs of both sexes had a
Gln/Glu-ratio of 0.5, whereas n-3 PUFA-fed SHRs
of both sexes showed a significant 21% increase of
Gln/Glu ratios (p = 4.9 × 10-4). These latter results
approached those observed in the WKY controls,
where both sexes showed a 33% higher Gln/Glu ratio
than that observed in the control-fed SHRs (p = 3.2 ×
10-4), with a mean value of 0.7. Hence, n-3 PUFA-
feeding appeared to reverse the abnormally low Gln/
Glu ratio in the control-fed SHRs towards control
WKY-values in both sexes of the SHR animals
(Figure 6c). Thus, our data suggest that control-fed
SHR animals had a subnormal glutamatergic activity,
and that this was partly normalized in the n-3 PUFA-
supplemented animals.
In addition to these changes in the major neurotrans-
mitter monoamines and amino acids, minor effects were
also seen in glycine (Gly). This bifunctional amino acid,
which is active both as an inhibitory transmitter in the
brain stem and spinal cord, and as an obligatory co-
ligand of the NMDA-type of Glu receptor in excitatory
synapses [50,51], was significantly increased after n-3
PUFA-supplementation in both SHR sexes. When com-
pared to the male and female WKY controls, neostri-
atal Gly levels were significantly lower in control-fed
SHRs of both sexes (by 42 and 28%, p = 2.4 × 10-4 and
a b c
Figure 5 Serotonin (5-HT) and 5-hydroxyindole-3-acetic acid (5-HIAA) levels in neostriatum. n-3 PUFA supplementation modulates 5-HT
turnover in both male and female SHR rats. Levels of (a) 5-HT and (b) 5-HIAA were used to determine (c) 5-HIAA/5-HT ratios. The data are
presented as means ± SEM (n = 4–8) and the level of significance is symbolized with * (p-value≤ 0.05), ** (p-value≤ 0.01) or *** (p-value≤ 0.001).
The p-values are calculated by comparison with the mid bar, which represents control-fed SHRs. The analyses were performed by HPLC using
electrochemical detection.
a b c
Figure 4 Dopamine (DA) and homovanillic acid (HVA) levels in neostriatum. n-3 PUFA supplementation modulated DA turnover in male
SHR: (a) DA and (b) HVA levels were used to determine (c) HVA/DA ratios. Data are presented as means ± SEM (n = 4–8) and the level of
significance is symbolized by * (p-value≤ 0.05), ** (p-value≤ 0.01) or *** (p-value≤ 0.001). The p-values are calculated by comparison with the
mid bar representing control-fed SHRs. The analyses were performed by HPLC using electrochemical detection.
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p= 0.04), respectively (Figure 7). Following n-3 PUFA
supplementation, Gly levels were changed to a level
similar to what was seen in WKY neostriata, by 24 and
28% increases (p = 0.03 and p = 0.05), respectively. Thus,
our observations imply both a genetic difference be-
tween the Gly systems in the SHR and WKY strains and
an effect of n-3 PUFAs on the metabolism of neostriatal
Gly in the SHRs.
In contrast to the glycinergic system, n-3 PUFA feed-
ing had no significant effect on GABA levels in the SHR
of either sex. Hence, the diet-induced major changes in
excitatory glutamatergic fibers as well as the modulatory
dopaminergic and serotoninergic synaptic inputs to the
neostriatal cells seen in the SHR animals (see above), did
not lead to major changes in the local GABAergic trans-
mission present in neostriatum.
Finally, the levels of Asp and Ser were unchanged by
dietary n-3 PUFAs in both male and female SHRs.
Moreover, although the concentration of taurine (Tau)
appeared to respond to n-3 PUFA feeding by decreasing
levels in both male and female SHRs, these changes were
not significant (p = 0.08 and 0.065 respectively). A poten-
tial effect of Tau in modulating DA release in the ventral
striatum, of importance for reinforcement mechanisms
[52] and possibly ADHD in the SHR, therefore remains
uncertain. These data also support the idea that n-3 PUFA
supplementation predominantly affects synaptically active
amino acids and not general amino acid metabolism.
Discussion
In this study, dietary n-3 PUFA supplementation to
SHRs was associated with two distinct types of changes
a b c
Figure 6 Glutamate (Glu) and glutamine (Gln) levels in neostriatum. n-3 PUFA supplementation modulates Gln/Glu turnover in both male
and female SHR rats. Levels of (a) Glu and (b) Gln were used to determine (c) Gln/Glu ratios. Control-fed SHRs of both sexes showed significant
ratio reductions when compared to WKY controls, and n-3 PUFA feeding reversed these ratios in both SHR sexes. Data are presented as
means ± SEM (n = 4–8) and the level of significance is marked with * (p-value≤ 0.05), ** (p-value≤ 0.01) or *** (p-value≤ 0.001). The p-values are
calculated by comparison with the mid bar representing control SHRs.
Figure 7 Concentrations of amino acids in neostriatal extracts. Both male and female control-fed SHRs showed significantly reduced levels
of glycine (Gly) when compared to WKY controls, and n-3 PUFA supplementation increased Gly levels significantly in both SHR sexes. In contrast,
GABA levels from SHR controls were significantly lower than in WKY controls of both sexes, and n-3 PUFA supplementation did not change the
level of GABA. Taurine (Tau) levels were significantly lower in the male SHR controls than in the male WKY controls. n-3 PUFA supplementation
promoted a small, non-significant decrease in Tau levels in both sexes. Aspartate (Asp) and serine (Ser) remained unchanged. Data are
presented as means ± SEM (n = 4–8), and the level of significance is symbolized with * (p-value≤ 0.05), ** (p-value≤ 0.01) or *** (p-value≤ 0.001).
The p-values are calculated by comparison with the mid bar representing control-fed SHRs.
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in ADHD-like behaviours which occured in synchrony
with changes in neurotransmitter systems. One of these
included reduced levels of reinforcer-controlled activity,
impulsiveness and inattention in male SHR, with no or
opposite effects in the female SHRs. Neurotransmitter
dynamics in neostriatum of these animals were also
changed, showing enhanced DA and 5-HT turnover,
which again were predominantly seen in male SHRs. In
contrast, the other change included a reduction in gen-
eral locomotor activity in both SHR sexes, which
appeared to correlate with changes in levels of several
neuroactive amino acids in both male and female SHRs.
Thus, our data indicate major sex-specific effects on
neurotransmitter systems in the PUFA-fed animals, with
the males having unique enhancements of both DA and
5-HT in the neostriatum [53]. Although the 5-HT deg-
radation product 5-HIAA also was significantly
increased in females, with a similar turnover ratio to that
seen in males, the turnover in female SHRs was not sta-
tistically significant. Even though the mechanisms be-
hind these effects of n-3 PUFAs are unclear [9,27,54,55],
our data correlate well with the behavioural observa-
tions, which also showed sex differences, with males im-
proving on all operant measures, whereas females did
not. This similarity suggests a possible causal relation
between the n-3 PUFA-induced increase of modulatory
neurotransmission [56] and improved behaviour [36].
Reinforcement mechanisms in the CNS are mostly
mediated via DA synapses [57-59], which are heavily
concentrated in neostriatal brain regions, particularly in
the dorsal and ventral caudate-putamen [60]. Here, exci-
tatory Glu inputs from cerebral cortex and thalamus
predominantly terminate on efferent GABAergic cells,
with the widely distributed DA and 5-HT modulatory
synaptic inputs from the brain stem having the ability to
modulate the efficacy of the Glu-to-GABA synapses,
thereby determining to what extent efferent GABAergic
information will be transmitted out of the basal ganglia
[61]. This synaptic effect, mediated trough an undefined
mechanism being involved in the neurobiological
changes occurring in the n-3 PUFA-fed animals, may
suggest enhanced action potential firing frequencies,
structural synaptic changes (e.g. increased number of
vesicles or synapses) or enhanced biochemical capacity,
vesicle storage capacity or enhanced neurotransmitter
levels [62-66].
In contrast, effects on locomotion appear to represent
a distinct target, with general, non-operant locomotion
activities being sensitive to n-3 PUFAs in both sexes.
Given that the locomotion occurred continuously during
the operant test, and that frame-to-frame analyses of
video-recordings detected changes in pixels whenever
the animals moved, it is clear that this measure reflected
both operant behaviour controlled by the scheduled
reinforcers as well as general movements. The interpret-
ation that operant behaviour and video-measured loco-
motion represent two distinct phenomena is also
supported by the dissociation of reinforcement-
controlled lever pressing and changes in the video-
measured locomotion observed in female SHRs, where
n-3 PUFA feeding increased levels of operant responses
but reduced initial video-measured locomotion.
Because the PUFA-induced reduction in non-operant
behaviour locomotor activity occurred in both sexes, it
is of great interest that those neuroactive transmitter
amino acids which responded to n-3 PUFAs also showed
similar patterns in the two sexes. Specifically, these
included reduced plasma levels of Glu and enhanced
levels of Gly, with no changes in Gln and GABA. Be-
cause the Gln/Glu ratio was significantly increased, glu-
tamatergic neurotransmission in neostriatum of the
SHRs may be enhanced by dietary n-3 PUFA supple-
mentation in both sexes. Previous analysis has suggested
that motor activity may be modulated by Glu receptor
activation [33], in agreement with our observations.
The levels of Gly showed similar differences as those
found in the Gln/Glu ratios; with low levels in the
control-fed SHRs, and PUFA-induced increase in levels
seen in both SHR sexes. Although Gly receptors are
present in the rat striatum, and are proposed to modu-
late both cholinergic, dopaminergic and glutamatergic
transmission [67-69], the importance of increased Gly
levels in the striata of n-3 PUFA supplemented SHRs
remains unknown [70-73]. Previous work has also indi-
cated changes in Tau levels in male SHRs when com-
pared to WKY controls [74], suggesting a possible role
for Tau in association with ADHD. Indeed, Tau changes
may lead to impaired regulation of Gly, GABA and/or
DA signalling [52,75-78]. However, Tau levels were only
insignificantly reduced following n-3 PUFA feeding,
making it unlikely that these changes represent an im-
portant mechanism for mediating n-3 PUFA-induced
amelioration.
Finally, the PUFA-induced normalization of the Gln/
Glu ratios as well as Gly levels, which occur in both fe-
male and male SHRs, is of considerable interest. This
contrasts to the major PUFA-induced changes found in
the DA and 5-HT turnover, seen predominantly in the
male SHRs. Intuitively, these dietary effects of n-3 PUFA
in ADHD models like SHR would be expected to
normalize both groups of neurotransmitters. However,
given the well-known distinct functional organizations
of the quantitatively predominant amino acidergic
synapses in the neostriatum as compared to the minor
but widespread modulatory monoaminergic synaptic sys-
tems [79], our data appear consistent with the interpret-
ation that n-3 PUFA feeding induced strong activation
of the modulatory DA and 5-HT systems in order to
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normalize the functionally more important amino acid-
ergic neurotransmitter systems. It should also be empha-
sized that our study only represents a small number of
possible factors involved in ADHD-development. More-
over, other studies have also observed sex differences in
other important neurochemical parameters like the
dopamine D1 and D2 receptors [80], or monoamine-
catabolizing enzymes like COMT [81,82]. Finally, a
potential weakness of our study is that the control group
is fed considerably less fat than the n-3 PUFA-fed group.
However, recent studies [83] demonstrated that adult
male Long Evans rats given a high-fat diet developed a
decrease, not an increase in their DA turnover in the
ventral striatum, making it highly unlikely that the high-
fat diet per se employed in this study is responsible for
the enhancement of DA turnover which occures in the
male SHRs.
Conclusion
Our study indicates that dietary supplementation of n-3
PUFA to SHR dams and their offspring induces two
distinct sets of changes in the offsprings: The first
included activation of presynaptic neostriatal DA and
5-HT signalling as well as several reinforcement mechan-
isms [84], all restricted to the male SHR, suggesting that
this effect may preferentially improve male ADHD-like
symptoms; In contrast the second included a non-
reinforcement but PUFA-induced improvement in beha-
vioural responses in both male and female ADHD
animals, and changing amino acid transmitters to the
same extent in both sexes. Thus, n-3 PUFA may partly
ameliorate ADHD-like behaviour via reinforcer-induced
systems restricted to males, and partly via reinforcer-
insensitive systems present in both sexes.
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